Analyst: Qudus Adebara (Founder of Wane Investment House, Nigeria) Executive Summary NVIDIA Corporation delivered a record performance for the third quarter ended October 26, 2025, with revenue of $57.0 billion, up 62% YoY and 22% QoQ , reflecting robust demand across AI, cloud, and data center workloads. The company’s gross margins remained exceptionally high at 73.4% GAAP and 73.6% non-GAAP , supported by operational efficiency and the strong adoption of NVIDIA Blackwell and Rubin systems.Read more

Okay, so you are probably thinking… yeah right, here’s that degenerate Double Bubbler banging on about that penny stock again. Well take a brief moment and read the following to see why my opinion is not so outlandish.Read more

Analyst: Qudus Adebara (Research Analyst) Executive Summary VFD Group Plc delivered a solid FY 2025 performance marked by strong balance sheet expansion, resilient core investment income, and exceptional comprehensive income growth , despite persistent pressure from elevated finance costs and higher impairment charges. For the year ended December 31, 2025, the Group recorded Profit After Tax (PAT) of ₦9.68 billion , representing an 11.4% YoY increase , supported by strong fair value gains on equity investments and disciplined cost control.Read more

Analyst: Qudus Adebara (Research Analyst) Executive Summary Dangote Sugar Refinery Plc recorded a strong topline expansion for the year ended 31 December 2025, driven by higher sugar volumes and improved regional performance. Revenue increased by 25% YoY to ₦829.2 billion , largely supported by 50kg sugar sales across major regions.Read more

Analyst: Qudus Adebara Executive Summary Oando Plc delivered a mixed and highly volatile performance for the twelve months ended 31 December 2025. Group revenue declined by 21.4% YoY to ₦3.21 trillion (FY 2024: ₦4.09 trillion), reflecting weaker trading volumes in the Supply & Trading segment and pressure across energy markets.Read more

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.Read more

Analyst: Qudus Adebara Executive Summary Caverton Offshore Support Group Plc delivered a significantly improved operating performance for the year ended 31 December 2025, driven by cost rationalization and strong other operating income. However, heavy finance costs and foreign exchange losses resulted in a full-year net loss.Read more

PRESCO operates in Oil Palm sector which has high entry cost and long gestation period. PRESCO has high margins (Gross & Net) and pricing power with specialized products including RBDO.Read more

Analyst: Qudus Adebara (Research Analyst) Executive Summary Lafarge Africa Plc delivered an outstanding financial performance for the year ended 31 December 2025, supported by strong cement revenue growth, improved cost efficiency, foreign exchange gains, and significantly lower finance costs. Revenue increased by 53% YoY to ₦1.066 trillion , driven primarily by cement sales.Read more